Injected contrast improved liver ultrasound sensitivity and specificity in malignant liver lesions, aiding diagnosis in 13.7% of cases in a French study. Researchers concluded that contrast-enhanced ultrasound should be routine practice when considering surgical management of hepatic lesions.
Injected contrast improved liver ultrasound sensitivity and specificity in malignant liver lesions, aiding diagnosis in 13.7% of cases in a French study. Researchers concluded that contrast-enhanced ultrasound should be routine practice when considering surgical management of hepatic lesions.
Dr. Linda Chami and colleagues at the Institut Gustave Roussy in Villejuif examined 116 patients, first with conventional ultrasound, then with contrast-enhanced ultrasound combined with perfusion software - either vascular recognition or pulse subtraction imaging. Histological results served as the standard for judging sensitivity and specificity for both exams.
The researchers published their study in the March issue of the American Journal of Roentgenology.
Of the 116 patients, 82 were treated surgically, 31 didn't qualify for surgery because of disseminated lesions, and three didn't meet the study's inclusion criteria. Surgery identified 306 hepatic lesions, and histopathologic analysis showed 233 were malignant and 73 benign.
Baseline sonography detected a total of 147 lesions, while contrast-enhanced sonography detected 177. When compared with the histological results, contrast-enhanced sonography detected 23 more malignant lesions than did the baseline exam. These had been identified as lacunae at the portal venous phase and benign nodules on baseline sonography.
The researchers found that contrast-enhanced ultrasound had a sensitivity of 68.7% and specificity of 67%, while baseline ultrasound had a sensitivity of 58.8% and specificity of 50.7%.
Injected contrast improved liver ultrasound exam results in 13.7% of cases. The researchers concluded that it should become part of routine assessment of hepatic lesions prior to surgery.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
What New Research Reveals About ChatGPT and Ultrasound Detection of Thyroid Nodules
March 13th 2024In a comparison of image-to-text large language models (LLMs), ChatGPT 4.0 offered a 95 percent sensitivity rate and an 83 percent AUC that were comparable to that of two senior radiologists and one junior radiologist interacting with LLM to differentiate between malignant and benign thyroid nodules on ultrasound.
ECR Study Finds Mixed Results with AI on Breast Ultrasound
March 6th 2024While adjunctive use of AI led to significantly higher specificity and accuracy rates in detecting cancer on breast ultrasound exams in comparison to unassisted reading by breast radiologists, researchers noted that 12 of 13 BI-RADS 3 lesions upgraded by AI were ultimately benign, according to research presented at the European Congress of Radiology.